Pomerantz Roger 4
4 · Indaptus Therapeutics, Inc. · Filed Jun 7, 2024
Insider Transaction Report
Form 4
Pomerantz Roger
Director
Transactions
- Award
Stock Option (right to buy)
2024-06-06+30,000→ 30,000 totalExercise: $2.63Exp: 2034-06-06→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable on June 6, 2025.